Report Description

Global ELISA test market is expected to grow at a significant rate for the forecast period on account of increasing prevalence of infectious disease such as dengue, AIDS, neurological disorders, hepatitis, cancer, among others. According to WHO, HIV continues to be a major global public health ailment, taken lives of approx. 40.1 million deaths so far. In 2021, 650,000 people died due to HIV-related causes and around 1.5 million people acquired HIV. Rising need for cost-effective and more efficient tools for diagnostic procedures in medical sector is fueling the growth of the ELISA test market. ELISA techniques are used extensively in healthcare for the diagnosis of various infectious diseases, including HIV, hepatitis B and C, and Lyme disease, as well as for cancer diagnosis and monitoring. As healthcare expenditure continues to rise globally, there is a growing demand for more efficient, accurate, and cost-effective diagnostic techniques, such as ELISA.ELISA technique has several advantages over other diagnostic techniques such as it is relatively inexpensive, easy to perform, and can be adapted to detect a wide range of infectious agents. ELISA is also highly sensitive and specific, that it can detect even small amounts of antigens or antibodies in a sample.

Increasing Prevalence of Infectious Diseases

ELISA is used to screen large numbers of samples for the presence of infectious agents, such as HIV, hepatitis B and C, and Lyme disease. ELISA is used to diagnose infectious diseases by detecting the presence of antigens or antibodies in patient samples, such as blood, urine, or saliva. ELISA has its application in monitoring the progression of infectious diseases by measuring changes in antigen or antibody levels over time. Growing prevalence of infectious disease such as dengue, hepatitis, AIDS, neurological disorders, and cancer is observed across worldwide. According to the WHO statistics, in 2019, hepatitis B there were approximately 82,0000 deaths resulting from, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer). Also, serological diagnosis by IgM/IgG MAC ELISA has been the most common method of confirmation of dengue fever. According to the WHO’s global burden of disease statistics the incidence of dengue has grown dramatically around the world in recent decades, with cases reported to WHO increased from 505 430 cases in 2000 to 5.2 million in 2019. Thus, with the increasing prevalence of the infectious disease, diagnostic tests are subjected to be more in demand thereby ELISA being the safe and efficient method to diagnose infectious diseases such as viral infections are more in demand and at the same time is expected to support the market growth in the forecast period.

Application in Various Disease Diagnosis

ELISA test is used to identify proteins, antibodies, hormones, and peptides. ELISA test finds application in diverse end-user industries such as biochemistry, pharmaceuticals and for diagnosis of pregnancy and HIV in patients. ELISA is used to measure the enzyme activity along with measurement of cytokines, soluble proteins, and others.

According to the Centers for Disease Control and Prevention (CDC), In 2018, it was observed that around 1.7 million infections and 99,000 deaths occur each year in the American hospitals. Moreover, the surge in demand for point of care testing is anticipated to fuel the growth of the global ELISA test market.

ELISA can serve an effective tool in measuring cancer markers or tumor markers and selectable biomolecules that are present in the body in the antigenic form in response to cancer growth and development. The ease of purchasing prepackaged, ready-to-use reagents and the dependability that comes from validation and quality control are both provided by ELISA kits that target cancer marker antigens and thus increase the ELISA test market demand and with the increasing cancer prevalence, is expected to boost the market growth in the upcoming future.

Increasing healthcare expenditure and awareness

Rise in disposable income among the middle-class families is aiding in increasing the healthcare expenditure capacity of the patients thereby preferring the quality treatment for their diseases. Growing awareness of the importance of early detection and prevention of diseases, which is driving the demand for diagnostic testing. Patients and healthcare providers are recognizing the benefits of early diagnosis, which can lead to better outcomes and lower healthcare costs in the long run. ELISA techniques are highly sensitive and specific, making them an attractive option for diagnostic laboratories and research institutions. Increase in public campaigns across the globe to raise awareness regarding the symptoms of infectious disease plays a crucial role in prevention of disease is attributing to high demand for ELISA test world-wide, thereby supporting the market. Moreover, Other benefits of ELISA test are reduced assay time, requirement of antisera for analysis and quantitative results, thus ELISA being more in demand due to its applications and thereby is anticipated to support the market growth in the forecast period.

Frequent Testing Need Among the Geriatric Population

The geriatric population is rising across the world and thus the increase in hospitalization rate. The elderly often has weakened immune systems, making them more susceptible to infections, and their bodies may not respond as effectively to vaccines. Frequent testing can help detect infections early and prevent their spread to other vulnerable individuals in the community. In addition, many elderly individuals have multiple chronic conditions, frequent testing can help monitor these conditions and ensure that appropriate interventions are taken to prevent disease progression. The growing aging population leads to increased susceptibility to infectious diseases on the According to WHO, by 2030 ,1 in every 6 people in the world will be aged above 60 years and the global population for the aged people with 60 above ages will rise from 1 billion in 2020 to 1.4 billion by 2030. According to the statistics by journal of global health, the most common infectious disease among the elderly population were respiratory and mucocutaneous diseases, which has observatory increase of 17.45% and 20.44% respectively. Thus, as the elderly are facing a substantial challenge with infectious diseases, thereby they are subjected to quick and efficient testing and thereby creating a huge demand for diagnosing testing such as ELISA and thereby are anticipated to support the Global ELISA market in the forecast period.

Application Of ELISA in Forensic Sciences

The application of ELISA in diagnosis of foreign specimens for potential application in forensic toxicology blood screening programs. Biological samples can be examined using the testing method. For the toxicology testing specifically, ELISA is an effective and cost-efficient solution to fulfil high throughput screening needs and get accurate results. ELISA is an efficient techniques for detection of substance toxicology when screening is scaled up to the large volume applications, both in terms of cost and speed. . For instance, the test kits included many drugs of abuse that fall under the drug of abuse category such as cocaine and metabolites, cannabinoids, phencyclidine (PCP), amphetamines, and opiates, Tobacco, methadone, benzodiazepines, designer drugs, and synthetic cathinones, etc,. The ELISA technique operate incredibly well on a variety of human sample grounds, including hair, oral fluid, serum, blood, urine, plasma, and other forensic samples.


Download Free Sample Report

Market Segmentation

Global ELISA test market is segmented into method, application, technology, end user, regional distribution, and company. Based on the type of method, the ELISA Test Market is segmented into, Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA. Based on the application, the market is grouped into, Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation and Others. Depending on the technology the market is segmented into Chemiluminescent, Colorimetric, Fluorescent. Based on the End User, the market is fragmented into Hospitals, Diagnostic Centers, Research Laboratories and Others.

Market Players

F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Enzo Life Sciences, Inc., BioLegend, Inc., ELISA Technologies, Inc., RayBiotech, Inc., Eurofins Scientific Ltd, are some of the major players operating in the global ELISA test market.

 Attribute

Details

Base Year

2022

Historical Years

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Method

·         Application

·         Technology

·         End User

Regional Scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa;

Key Companies Profiled

F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Enzo Life Sciences, Inc., BioLegend, Inc., ELISA Technologies, Inc., RayBiotech, Inc., Eurofins Scientific Ltd.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global ELISA test market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • ELISA Test Market, By Method:
    • Direct ELISA
    • Indirect ELISA
    • Sandwich ELISA
    • Competitive ELISA
  • ELISA Test Market, By Application:
    • Vaccine Development
    • Immunology
    • Diagnostics
    • Toxicology
    • Drug Monitoring and Pharmaceutical Industry
    • Transplantation
    • Others
      • Infectious Diseases
      • Cancer
      • Protein Quantitation
  • ELISA Test Market, By Technology:
    • Chemiluminescent
    • Colorimetric
    • Fluorescent
  • ELISA Test Market, By End User:
    • Hospitals
    • Diagnostic Centers
    • Research Laboratories
    • Others
  • ELISA Test Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
  • South Korea
      • Australia
  • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global ELISA test market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global ELISA test market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Clinical Trial Analysis

5.1.  Ongoing Clinical Trials

5.2.  Completed Clinical Trials

5.3.  Terminated Clinical Trials

5.4.  Breakdown of Pipeline, By Development Phase

5.5.  Breakdown of Pipeline, By Status

5.6.  Breakdown of Pipeline, By Study Application

5.7.  Breakdown of Pipeline, By Region

5.8.  Clinical Trials Heat Map

6.    Global ELISA Test Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA)

6.2.2.    By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others (Infectious Diseases, Cancer, Protein Quantitation)

6.2.3.    By Technology (Chemiluminescent, Colorimetric, Fluorescent)

6.2.4.    By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others)

6.2.5.    By Company (2022)

6.2.6.    By Region

6.3.  Market Map

6.4.   

7.    Asia-Pacific ELISA Test Market Outlook

7.1.  Market Size & Forecast        

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Method

7.2.2.    By Application

7.2.3.    By Technology

7.2.4.    By End User

7.2.5.    By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.    China ELISA Test Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.            By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.            By Method

7.3.1.2.2.            By Application

7.3.1.2.3.            By Technology

7.3.1.2.4.            By End User

7.3.2.    India ELISA Test Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.            By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.            By Method

7.3.2.2.2.            By Application

7.3.2.2.3.            By Technology

7.3.2.2.4.            By End User

7.3.3.    Japan ELISA Test Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.            By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.            By Method

7.3.3.2.2.            By Application

7.3.3.2.3.            By Technology

7.3.3.2.4.            By End User

7.3.4.    South Korea ELISA Test Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.            By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.            By Method

7.3.4.2.2.            By Application

7.3.4.2.3.            By Technology

7.3.4.2.4.            By End User

7.3.5.    Australia ELISA Test Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.            By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.            By Method

7.3.5.2.2.            By Application

7.3.5.2.3.            By Technology

7.3.5.2.4.            By End User

8.    Europe ELISA Test Market Outlook

8.1.  Market Size & Forecast        

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Method

8.2.2.    By Application

8.2.3.    By Technology

8.2.4.    By End User

8.2.5.    By Country

8.3.  Europe: Country Analysis

8.3.1.    France ELISA Test Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.            By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.            By Method

8.3.1.2.2.            By Application

8.3.1.2.3.            By Technology

8.3.1.2.4.            By End User

8.3.2.    Germany ELISA Test Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.            By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.            By Method

8.3.2.2.2.            By Application

8.3.2.2.3.            By Technology

8.3.2.2.4.            By End User

8.3.3.    United Kingdom ELISA Test Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.            By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.            By Method

8.3.3.2.2.            By Application

8.3.3.2.3.            By Technology

8.3.3.2.4.            By End User

8.3.4.    Italy ELISA Test Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.            By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.            By Method

8.3.4.2.2.            By Application

8.3.4.2.3.            By Technology

8.3.4.2.4.            By End User

8.3.5.    Spain ELISA Test Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.            By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.            By Method

8.3.5.2.2.            By Application

8.3.5.2.3.            By Technology

8.3.5.2.4.            By End User

9.    North America ELISA Test Market Outlook

9.1.  Market Size & Forecast        

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Method

9.2.2.    By Application

9.2.3.    By Technology

9.2.4.    By End User

9.2.5.    By Country

9.3.  North America: Country Analysis

9.3.1.    United States ELISA Test Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.            By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.            By Method

9.3.1.2.2.            By Application

9.3.1.2.3.            By Technology

9.3.1.2.4.            By End User

9.3.2.    Mexico ELISA Test Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.            By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.            By Method

9.3.2.2.2.            By Application

9.3.2.2.3.            By Technology

9.3.2.2.4.            By End User

9.3.3.    Canada ELISA Test Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.            By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.            By Method

9.3.3.2.2.            By Application

9.3.3.2.3.            By Technology

9.3.3.2.4.            By End User

10.  South America ELISA Test Market Outlook

10.1.             Market Size & Forecast         

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Method

10.2.2. By Application

10.2.3. By Technology

10.2.4. By End User

10.2.5. By Country

10.3.             South America: Country Analysis

10.3.1. Brazil ELISA Test Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Method

10.3.1.2.2.         By Application

10.3.1.2.3.         By Technology

10.3.1.2.4.         By End User

10.3.2. Argentina ELISA Test Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Method

10.3.2.2.2.         By Application

10.3.2.2.3.         By Technology

10.3.2.2.4.         By End User

10.3.3. Colombia ELISA Test Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Method

10.3.3.2.2.         By Application

10.3.3.2.3.         By Technology

10.3.3.2.4.         By End User

11.  Middle East and Africa ELISA Test Market Outlook

11.1.             Market Size & Forecast         

11.1.1. By Value

11.2.             Market Share & Forecast

11.2.1. By Method

11.2.2. By Application

11.2.3. By Technology

11.2.4. By End User

11.2.5. By Country

11.3.             MEA: Country Analysis

11.3.1. South Africa ELISA Test Market Outlook

11.3.1.1.     Market Size & Forecast

11.3.1.1.1.         By Value

11.3.1.2.     Market Share & Forecast

11.3.1.2.1.         By Method

11.3.1.2.2.         By Application

11.3.1.2.3.         By Technology

11.3.1.2.4.         By End User

11.3.2. Saudi Arabia ELISA Test Market Outlook

11.3.2.1.     Market Size & Forecast

11.3.2.1.1.         By Value

11.3.2.2.     Market Share & Forecast

11.3.2.2.1.         By Method

11.3.2.2.2.         By Application

11.3.2.2.3.         By Technology

11.3.2.2.4.         By End User

11.3.3. UAE ELISA Test Market Outlook

11.3.3.1.     Market Size & Forecast

11.3.3.1.1.         By Value

11.3.3.2.     Market Share & Forecast

11.3.3.2.1.         By Method

11.3.3.2.2.         By Application

11.3.3.2.3.         By Technology

11.3.3.2.4.         By End User

12.  Market Dynamics

12.1.             Drivers

12.2.             Challenges

13.  Market Trends & Developments

13.1.             Recent Developments

13.2.             Mergers & Acquisitions

13.3.             Product Developments

14.  Competitive Landscape

14.1.             Business Overview

14.2.             Company Snapshot

14.3.             Products & Services

14.4.             Financials (In case of listed companies)

14.5.             Recent Developments

14.6.             SWOT Analysis

14.6.1. F. Hoffmann-La Roche Ltd.

14.6.2. Thermo Fisher Scientific Inc.

14.6.3. Becton, Dickinson and Company

14.6.4. Bio-Rad Laboratories, Inc.

14.6.5. bioMérieux SA

14.6.6. Enzo Life Sciences, Inc.

14.6.7. BioLegend, Inc.

14.6.8. ELISA Technologies, Inc.

14.6.9. RayBiotech, Inc.

14.6.10.               Eurofins Scientific Ltd.

15. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Factors such as increasing prevalence of infectious disease such as dengue, AIDS, neurological disorders, hepatitis, cancer and rising need for cost-effective and more efficient tools for diagnostic procedures are driving the growth of the global ELISA test market in the forecast period.

down-arrow

The global ELISA test market analysis was analyzed for the five historical years from 2018 to 2021. Keeping the base year 2021 as the margin, the estimation for the year 2023 was made and further market growth is predicted for the forecast years, 2024 to 2028.

down-arrow

North America region is expected to dominate the market for the forecast period on account of a well-established healthcare infrastructure and increasing penetration of medical devices in the region.

down-arrow

F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Enzo Life Sciences, Inc., among others are some of the major companies leading the global ELISA test market.

profile

Sakshi Bajaal

Business Consultant
Press Release

North America to dominate the Global ELISA Test Market till 2026

Jul, 2021

Increasing need for accurate and quick diagnosis is expected to drive the demand for global ELISA test market in the forecast period.